Table 1 Characteristics of study participants, EURIKA Study 2009 - 2010

N

7,434 (100.0)

630 (8.1)

555 (7.5)

619 (8.3)

631 (8.5)

632 (8.5)

604 (8.1)

641 (8.6)

594 (8.0)

593 (8.0)

614 (8.3)

655 (8.8)

666 (9.0)

Age (years)

63.2 (9.0)

64.6 (8.9)

64.2 (8.8)

62.9 (8.9)

63.1 (9.8)

65.3 (9.9)

61.8 (8.6)

65.5 (8.8)

62.9 (8.5)

58.3 (7.3)

64.9 (8.6)

59.4 (7.6)

65.0 (8.9)

Sex

   Men

3,584 (48.2)

309 (49.1)

301 (54.2)

284 (45.9)

323 (51.2)

336 (53.2)

288 (47.7)

313 (48.8)

292 (49.2)

184 (31.0)

307 (50.0)

308 (47.0)

339 (50.9)

   Women

3,850 (51.8)

321 (50.9)

254 (45.8)

335 (54.1)

308 (48.8)

296 (46.8)

316 (52.3)

328 (51.2)

302 (50.8)

409 (69.0)

307 (50.0)

347 (53.0)

327 (49.1)

Smoking

   Never

3,832 (51.6)

379 (60.2)

316 (56.9)

300 (48.5)

370 (58.6)

315 (49.8)

298 (49.3)

332 (51.8)

213 (35.9)

351 (59.2)

300 (48.9)

348 (53.1)

310 (46.6)

   Current

1,588 (21.4)

102 (16.2)

90 (16.2)

209 (33.8)

107 (17.0)

137 (21.7)

144 (23.8)

107 (16.7)

173 (29.1)

150 (25.3)

103 (16.8)

156 (23.8)

110 (16.5)

   Former

2,014 (27.1)

149 (23.7)

149 (26.9)

110 (17.8)

154 (24.4)

180 (28.5)

162 (26.8)

202 (31.5)

208 (35.0)

92 (15.5)

211 (34.4)

151 (23.1)

246 (36.9)

SBP (mmHg)*

135.0 (16.6)

132.6 (14.4)

133.2 (13.2)

129.8 (14.4)

133.9 (16.8)

136.1 (16.0)

135.3 (17.6)

135.3 (17.2)

136.6 (16.1)

136.5 (17.5)

140.1 (17.2)

134.4 (19.3)

136.3 (15.9)

DBP (mmHg)*

80.9 (9.9)

78.7 (8.2)

77.8 (8.9)

79.9 (8.8)

78.8 (10.2)

81.6 (10.0)

82.8 (9.7)

80.5 (9.5)

82.2 (9.9)

84.2 (10.3)

82.3 (9.7)

82.4 (11.6)

79.1 (9.9)

Hypertension

5,984 (80.5)

496 (78.7)

443 (79.8)

451 (72.9)

473 (75.0)

511 (80.9)

473 (78.3)

569 (88.8)

478 (80.5)

488 (82.3)

553 (90.1)

500 (76.3)

549 (82.4)

Uncontrolled

3,975 (53.5)

307 (48.7)

262 (47.5)

262 (42.4)

298 (47.3)

350 (55.4)

324 (53.7)

382 (59.6)

351 (59.1)

332 (56.1)

392 (64.0)

366 (56.0)

349 (52.5)

   hypertension

Tot. chol. (mmol/l)*

5.4 (1.1)

5.2 (1.0)

5.5 (1.1)

5.5 (1.1)

5.5 (1.1)

5.4 (1.1)

5.6 (1.2)

5.6 (1.1)

5.5 (1.1)

5.9 (1.2)

5.5 (1.2)

5.3 (1.1)

5.1 (1.2)

Dyslipidemia

6,646 (89.4)

560 (88.9)

508 (91.5)

582 (94.0)

581 (92.1)

568 (89.9)

544 (90.1)

577 (90.0)

548 (92.3)

532 (89.7)

550 (89.6)

509 (77.7)

587 (88.1)

Uncontrolled

5,185 (69.8)

376 (59.7)

401 (72.3)

438 (70.8)

459 (72.7)

433 (68.5)

457 (75.7)

486 (75.8)

436 (76.4)

484 (81.6)

424 (69.1)

446 (68.1)

345 (51.8)

   dyslipidemia

HbA1 c (%)*

6.1 (1.0)

5.9 (0.9)

5.9 (0.9)

6.0 (1.0)

6.0 (1.1)

6.0 (0.9)

6.0 (0.9)

6.1 (0.9)

5.9 (0.9)

6.3 (1.0)

6.1 (1.0)

6.5 (1.6)

6.0 (0.9)

Diabetes

2,200 (29.6)

182 (28.9)

144 (26.0)

189 (30.5)

190 (30.1)

205 (32.4)

156 (25.8)

255 (39.8)

145 (24.4)

143 (24.1)

171 (27.9)

246 (37.6)

174 (26.1)

Uncontrolled

1,415 (19.0)

98 (15.6)

89 (16.0)

110 (17.8)

117 (18.5)

121 (19.2)

94 (15.6)

140 (21.8)

86 (14.5)

117 (19.7)

131 (21.3)

191 (29.2)

121 (18.2)

   diabetes

10-y CVD risk (%)*

8.2 (9.8)

6.0 (7.2)

5.8 (6.3)

5.7 (6.7)

6.0 (6.7)

8.2 (10.1)

9.1 (10.9)

12.8 (13.2)

9.5 (9.8)

6.2 (7.7)

11.7 (12.4)

7.4 (9.3)

9.9 (10.6)

< 5%

3,690 (49.6)

370 (58.7)

331 (59.6)

383 (61.9)

384 (60.9)

326 (51.6)

282 (46.7)

194 (30.3)

238 (40.1)

369 (62.2)

204 (33.2)

360 (55.0)

249 (37.4)

5-10%

1,824 (24.5)

158 (25.1)

136 (24.5)

131 (21.2)

132 (20.9)

147 (23.3)

150 (24.8)

172 (26.8)

164 (27.6)

118 (19.9)

158 (25.7)

157 (24.0)

201 (30.2)

≥ 10%

1,920 (25.8)

102 (16.2)

88 (15.9)

105 (17.0)

115 (18.2)

159 (25.2)

172 (28.5)

275 (42.9)

192 (32.3)

106 (17.9)

252 (41.0)

138 (21.1)

216 (32.4)